Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Everett Meyer, Stanford University
ClinicalTrials.gov Identifier:
NCT01392989
First received: June 21, 2011
Last updated: April 18, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)